Pain Phenotyping in Multiple Sclerosis Based on IASP Criteria (clinicaltrials.gov)
New clinical trial Pain Phenotyping in Multiple Sclerosis Based on IASP Criteria
New clinical trial Pain Phenotyping in Multiple Sclerosis Based on IASP Criteria
New clinical trial An open-label phase I/II, single-center, interventional singlearm basket trial of UKT-CART19.1 in patients with relapsed/refractory autoimmune diseases
#mobilemedicaldevices #smarttechnology #healthwearables #MedicalDevices #patientaccess #consumerhealthcare #Digital #clinicaltrials #healthcare #Wearables #clinicaltrialprotocols #medicaldevicefeasibility #patienthealth #continuousdata #digitalendpoints #Rarediseaseresearch zurl.co/wIXIW
More cancer patients may become eligible for clinical trials. New FDA guidance encourages broader eligibility criteria, potentially opening studies to patients previously excluded because of health status & results. www.oncologynewscentral.com/oncology/fda...
New clinical trial Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
New clinical trial Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple Sclerosis: Multimodal Prospective Cohort Study at Assiut University Hospital